All News

In2Bones Announces the Global Launch of the TriWay® TibioTaloCalcaneal (TTC) Nail Arthrodesis System

April 30, 2019 MEMPHIS, Tenn.–(BUSINESS WIRE)–In2Bones Global, Inc. today announced the global launch of the TriWay® TibioTaloCalcaneal (TTC) Nail Arthrodesis System. Developed by a global team of surgeons and device experts, it represents an improved, best-in-class design compared with traditional cannulated systems used by foot and ankle surgeons. The new System features a unique posterior offset and solid nail …

Global Knee Reconstruction Market to Witness a CAGR of 5.3% during 2019-2025

NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) — The global knee reconstruction market was valued at USD 8,142 million in 2018, and is likely to generate a demand of USD 11,688 million by 2025, at a CAGR of 5.3% over the next seven years. The market growth is primarily attributed to the growing number of ageing population and increasing prevalence of rheumatoid arthritis. Moreover, …

Spineway : 2018 annual results

April 29, 2019 2018 annual resultsImplementation of the NEWWAY 2021 planStrategic acquisition in Latin America   In thousands of euros  Consolidated accounts20182017Revenue6 5159 138Gross margin% of revenue4 20164.5%6 15167.3%Operating revenue823574Operating expenses– 8 901– 7 571Operating income– 3 878– 845Net income– 4 124– 965 Spineway’s Board of Directors, at a meeting held on 26 April 2019 chaired by …

Medovex Corporation Announces Recent Management Appointments

ALPHARETTA, Ga., April 29, 2019 (GLOBE NEWSWIRE) — Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”), the owner and operator of innovative medical technology products and services including Lung Health Institute and the DenerveX® System, today announced a series of new management appointments bolstering its management team following the recent appointment of Bill Horne as Chief …

First Patient in New England Treated With the Agili-C™ Implant at CartiHeal’s Pivotal Study

KFAR SABA, Israel, April 29, 2019 /PRNewswire/ — Christian Lattermann, M.D., Chief of the Sports Medicine Service and Director of the Center for Cartilage Repair at Brigham and Women’s Hospital in Boston, recently became the first surgeon in New England to enroll a patient in CartiHeal‘s FDA – IDE study. Agili-C™ is an implant designed to regenerate the articular cartilage and its underlying …

Operating margins stabilize, but not-for-profit hospitals still vulnerable

April 26, 2019 / ALEX KACIK  Not-for-profit and public hospitals’ revenue growth has edged ahead of expense inflation for the first time since 2015, according to a new report. Median annual revenue growth rose to 5.1% while expense growth dropped to 5% in 2018, new preliminary data on 150 hospitals from Moody’s Investors Service show. …

Safe Orthopaedics announces its 2018 results and its revenues for the first quarter of 2019

April 26, 2019 ERAGNY-SUR-OISE, France–(BUSINESS WIRE)–Regulatory News: SAFE ORTHOPAEDICS (Paris:SAFOR) (FR0012452746 – SAFOR), a company specializing in the design and marketing of single-use implants and instruments for the minimally invasive treatment of spine fracture pathologies, today announced its 2018 annual results and its sales for the first quarter of 2019. The 2018 Registration Document including …

Zimmer Biomet Announces First Quarter 2019 Financial Results

WARSAW, Ind., April 26, 2019 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2019.  The Company reported first quarter net sales of $1.976 billion.  The effect of foreign currency exchange negatively impacted first quarter net sales by 2.8%, resulting in a reported net sales decrease of 2.1% from the …

Amplitude Surgical: Further Positive Momentum in Q3, 9-Month Sales of €76.6 million, +5% at Constant Exchange Rates

April 25, 2019 VALENCE, France–(BUSINESS WIRE)–Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible) (Paris:AMPLI), a leading French player on the global surgical technology market for lower-limb orthopedics, today announces its sales for the third quarter of its 2018-19 financial year. Olivier Jallabert, Chairman and CEO of Amplitude Surgical, says: “Amplitude Surgical recorded further …

Artoss, Inc. Announces FDA Clearance of NanoBone® SBX Putty for Standalone Use in Posterolateral Spinal Fusion

April 24, 2019 Artoss, Inc. is pleased to announce that the US Food & Drug Administration has cleared NanoBone SBX Putty for standalone use in posterolateral spinal fusion. NanoBone was tested alone (without addition of autograft or bone marrow aspirate) in the ASTM International standardized animal model and found to be equivalent to the “gold …

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1